Accessibility Menu

Basel Medical Group

(NASDAQ) BMGL

Current Price$8.35
Market Cap$13.07M
Since IPO (2025)-84%
5 YearN/A
1 Year-60%
1 Month+27%

Basel Medical Group Financials at a Glance

Market Cap

$13.07M

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-$4.85

P/E Ratio

-1.72

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Price

$8.35

Volume

207,795.328

Open

$7.00

Previous Close

$8.35

Daily Range

$6.90 - $10.60

52-Week Range

$4.60 - $54.60

Estimated Earnings Date

N/A

BMGL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Basel Medical Group

Industry

Healthcare Providers and Services

Employees

70

CEO

Darren Chhoa, PhD

Headquarters

Singapore, 188778, SG

BMGL Financials

Key Financial Metrics (TTM)

Gross Margin

-2.37%

Operating Margin

-31.66%

Net Income Margin

-67.66%

Return on Equity

-173.64%

Return on Capital

-26.36%

Return on Assets

-48.06%

Earnings Yield

-58.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.07M

Shares Outstanding

1.57M

Volume

207.80K

Avg. Volume

53.45K

Financials (TTM)

Gross Profit

-SGD 339.00K

Operating Income

-SGD 4.53M

EBITDA

-SGD 1.68M

Operating Cash Flow

-SGD 1.93M

Capital Expenditure

-SGD 643.31K

Free Cash Flow

-SGD 2.58M

Cash & ST Invst.

SGD 1.34M

Total Debt

SGD 9.87M

Basel Medical Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

SGD 8.24M

N/A

Gross Profit

-SGD 983.32K

N/A

Gross Margin

-11.93%

N/A

Market Cap

$13.07M

N/A

Market Cap/Employee

$408.49K

N/A

Employees

32

N/A

Net Income

SGD 268.44K

N/A

EBITDA

-SGD 860.60K

N/A

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

SGD 1.34M

+42.3%

Total Debt

SGD 9.87M

+72.1%

Accounts Receivable

SGD 12.25M

-11.4%

Inventory

SGD 332.76K

+201.9%

Long Term Debt

SGD 6.04M

+141.1%

Short Term Debt

SGD 3.83M

+18.7%

Return on Assets

-48.06%

N/A

Return on Invested Capital

-35.92%

N/A

Free Cash Flow

-SGD 1.75M

N/A

Operating Cash Flow

-SGD 1.63M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LDDDLongduoduo Company Limited
$0.51+0.00%
MODDModular Medical, Inc.
$4.60-1.71%
INTSIntensity Therapeutics, Inc.
$4.24+2.17%
TLPHTalphera, Inc.
$1.07+1.90%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
INTCIntel
$120.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%

Questions About BMGL

What is the current price of Basel Medical Group?

Basel Medical Group is trading at $8.35 per share.

What is the 52-week range for Basel Medical Group?

Over the past 52 weeks, Basel Medical Group has traded between $4.60 and $54.60.

How much debt does Basel Medical Group have?

As of the most recent reporting period, Basel Medical Group reported total debt of SGD 3.99M.

How much cash does Basel Medical Group have on hand?

Basel Medical Group reported SGD 2.39M in cash and cash equivalents in its most recent financial results.

What is Basel Medical Group’s dividend yield?

Basel Medical Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.